Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Asset Utilization Ratio (2016 - 2025)

Regenxbio has reported Asset Utilization Ratio over the past 11 years, most recently at 0.35 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.35 for Q4 2025, up 105.98% from a year ago — trailing twelve months through Dec 2025 was 0.35 (up 105.98% YoY), and the annual figure for FY2025 was 0.37, up 131.46%.
  • Asset Utilization Ratio for Q4 2025 was 0.35 at Regenxbio, up from 0.29 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for RGNX hit a ceiling of 0.52 in Q3 2022 and a floor of 0.11 in Q3 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.18 (2024), compared with a mean of 0.25.
  • Peak annual rise in Asset Utilization Ratio hit 359.18% in 2022, while the deepest fall reached 73.28% in 2022.
  • Regenxbio's Asset Utilization Ratio stood at 0.49 in 2021, then crashed by 73.28% to 0.13 in 2022, then increased by 13.81% to 0.15 in 2023, then rose by 13.21% to 0.17 in 2024, then soared by 105.98% to 0.35 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.35 (Q4 2025), 0.29 (Q3 2025), and 0.29 (Q2 2025) per Business Quant data.